For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
Category - cancer
Product（474）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KIFSEVTLK | ４°C | |||||
|
|
TC-8015-2 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | ４°C | ||||
|
|
TC-8004-2 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | ４°C | ||||
|
|
TS-M252-2 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | ４°C | |||||
|
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| ILDTAGREEY | ４°C | |||||
|
|
TC-8022-2 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | ||||
|
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TS-M271-2 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RVSTLRVSL | ４°C | |||||
|
|
TS-M267-1 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | ４°C | ||||
|
|
TC-8029-2 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TS-M260-2 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TS-M613-1 |
H-2Kb GLMP Tetramer-SALVFTRL-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| SALVFTRL | 119-126 | ４°C | ||||
|
|
TS-M252-1 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KILDAVVAQK | ４°C | |||||
|
|
TC-8023-1 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | ４°C | ||||
|
|
TS-M241-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | ４°C | |||||
|
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | ４°C | ||||
|
|
TC-8012-2 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | ４°C | ||||
|
|
TC-8034-1 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M269-1 |
HLA-B*07:02 UBR4 Neoepitope Tetramer-RPHVPESAF-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHVPESAF | ４°C | |||||
|
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | ４°C | |||||
|
|
TC-8005-2 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TS-M254-1 |
HLA-A*03:01 MYO1B Neoepitope Tetramer-KINKNPKYK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| KINKNPKYK | ４°C | |||||
|
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M262-2 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | ４°C | |||||
|
|
TS-M610-1 |
H-2Kb SGK1 Tetramer-STLTYSRM-PE |
|
|||
|
|
cancer | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| STLTYSRM | 10-17 | ４°C | ||||
|
|
TS-M230-2 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | ４°C | |||||
|
|
TS-M259-1 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | ４°C | |||||
|
|
TC-8021-1 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | ４°C | ||||
|
|
TC-8014-2 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TC-8013-1 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | ４°C | ||||
|
|
TC-8009-1 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | ４°C | ||||
|
|
TS-M258-2 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVGAAGVGK | ４°C | |||||
|
|
TS-M255-2 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | |||||
|
|
TS-M246-1 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | |||||
|
|
TS-M263-2 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TS-M259-2 |
HLA-A*11:01 HERC1 Neoepitope Tetramer-ASNASSAAK-APC |
|
|||
|
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| ASNASSAAK | ４°C | |||||
|
|
TS-M230-1 |
HLA-A*02:01 USP28 Neoepitope Tetramer-LIIPFIHLI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LIIPFIHLI | ４°C | |||||
|
|
TC-8033-1 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TC-8030-2 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | ||||
|
|
TS-M253-2 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | ４°C | |||||
|
|
TS-M276-1 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | ４°C | |||||
|
|
TC-8017-1 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | ４°C | ||||
|
|
TC-8014-1 |
HLA-A*11:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M274-2 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| CVRVSGQGL | ４°C | |||||
|
|
TC-8034-2 |
HLA-A*03:01 KRAS7-16 WT Tetramer-VVVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAGGVGK | 7-16 | ４°C | ||||
|
|
TS-M613-2 |
H-2Kb GLMP Tetramer-SALVFTRL-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| SALVFTRL | 119-126 | ４°C | ||||
|
|
TS-M234-2 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | ４°C | |||||
|
|
TS-M275-1 |
HLA-B*07:02 MYADM Neoepitope Tetramer-SPMIVGSPW-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPMIVGSPW | ４°C | |||||
|
|
TS-M211-1 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | ４°C | |||||
|
|
TS-M263-1 |
HLA-A*11:01 Perilipin-2 Tetramer-TSALPIIQK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| TSALPIIQK | 63-71 | ４°C | ||||
|
|
TC-8032-2 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | ||||
|
|
TS-M201-1 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-PE |
|
|||
|
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | ４°C | |||||
|
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | ４°C | ||||
|
|
TS-M268-2 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | ４°C | ||||
|
|
TS-M235-2 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | ４°C | |||||
|
|
TS-M270-1 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-PE |
|
|||
|
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | ４°C | |||||
|
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | ４°C | |||||
|
|
TC-8033-2 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-APC |
|
|||
|
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | ||||
|
|
TC-8013-2 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | ４°C | ||||
|
|
TC-8007-2 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | ４°C | ||||
|
|
TS-M247-2 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | |||||
|
|
TS-M260-1 |
HLA-A*11:01 CDK13 Neoepitope Tetramer-CILGKLFTK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| CILGKLFTK | ４°C | |||||
|
|
TC-8011-1 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | ４°C | ||||
|
|
TS-M273-2 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | ４°C | |||||
|
|
TS-M222-2 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | ４°C | |||||
|
|
TS-M262-1 |
HLA-A*11:01 KIF26B Neoepitope Tetramer-SSYTGFANK-PE |
|
|||
|
|
cancer | PE | A*11:01 | 50 tests |
0 (Contact us) |
|
| SSYTGFANK | ４°C | |||||
|
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | ４°C | |||||
|
|
TC-8017-2 |
HLA-A*02:01 AFP158-166 Tetramer-FMNKFIYEI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMNKFIYEI | 158-166 | ４°C | ||||
|
|
TC-8009-2 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | ４°C | ||||
|
|
TS-M610-2 |
H-2Kb SGK1 Tetramer-STLTYSRM-APC |
|
|||
|
|
cancer | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| STLTYSRM | 10-17 | ４°C | ||||
|
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | ４°C | |||||
|
|
TS-M211-2 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | ４°C | |||||
|
|
TS-M208-2 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | ４°C | |||||
|
|
TS-M247-1 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | |||||
|
|
TS-M220-1 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | ４°C | |||||
|
|
TS-M246-2 |
HLA-A*02:01 GOLGA3 Neoepitope Tetramer-SLDLTTSPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLDLTTSPV | ４°C | |||||
|
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | ４°C | |||||
|
|
TS-M214-2 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | ４°C | |||||
|
|
TS-M229-1 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | ４°C | |||||
|
|
TS-M266-1 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | ４°C | |||||
|
|
TC-8019-2 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | ４°C | ||||
|
|
TS-M276-2 |
HLA-B*07:02 DOPEY2 Neoepitope Tetramer-KPFCVLISL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPFCVLISL | ４°C | |||||
|
|
TS-M272-2 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | ４°C | |||||
|
|
TS-M232-2 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | ４°C | |||||
|
|
TS-M265-1 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | ４°C | |||||
|
|
TS-M253-1 |
HLA-A*03:01 GPNMB Neoepitope Tetramer-TLDWLLQTPK-PE |
|
|||
|
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| TLDWLLQTPK | ４°C | |||||
|
|
TS-M232-1 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | ４°C | |||||
|
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | ４°C | |||||
|
|
TS-M213-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | ４°C | |||||
|
|
TS-M224-2 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | ４°C | |||||
|
|
TS-M217-2 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | ４°C | |||||
|
|
TS-M216-2 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | ４°C | |||||
- The availability is based on the information in Japan at 00:05, Jun 13, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.